Home › Funds › Deep Track Capital, LP › ALMS
Deep Track Capital, LP position in ALMS
ALUMIS INC · Health Care
Deep Track Capital, LP reported holding 7,469,746 shares of ALMS (ALUMIS INC) in its Q3 2026 13F filing — a position valued at US$55.2M, representing 0.92% of its reported portfolio and ranking #34 among its reported holdings. Deep Track Capital, LP has disclosed ALMS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's ALMS position evolved
Deep Track Capital, LP first disclosed a stake in ALMS in Q1 2026 at 6,772,595 shares (US$149.2M). The position peaked in Q2 2026 at 6,348,558 shares, worth US$178.6M. Across 3 filings, Deep Track Capital, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 7,469,746 shares valued at US$55.2M — an increase of 1,121,188 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 6.77M | $149.20M | New |
| Q2 2026 | 6.35M | $178.65M | Reduce |
| Q3 2026 | 7.47M | $55.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALMS and 13F data
ALMS (ALUMIS INC) is a Health Care company. 59 other funds we track also report a position in ALMS — the largest reported positions include Samsara BioCapital, LLC (US$178.6M), Foresite Capital Management V, LLC (US$165.9M), venBio Partners LLC (US$127.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALMS
- Samsara BioCapital, LLC 6.35M sh · $178.55M · Q2 2026
- Foresite Capital Management V, LLC 5.90M sh · $165.94M · Q2 2026
- venBio Partners LLC 4.53M sh · $127.43M · Q2 2026
- Foresite Capital Management VI LLC 4.25M sh · $119.53M · Q2 2026
- AyurMaya Capital Management Company, LP 15.14M sh · $111.88M · Q3 2026
- Nextech Invest Ltd. 3.54M sh · $99.64M · Q2 2026
- Cormorant Asset Management, LP 3.29M sh · $92.46M · Q2 2026
- Octagon Capital Advisors LP 2.83M sh · $79.66M · Q2 2026
- MPM BioImpact LLC 2.02M sh · $56.82M · Q2 2026
- BAKER BROS. ADVISORS LP 2.01M sh · $56.63M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.96M sh · $55.15M · Q2 2026
- Novo Holdings A/S 1.10M sh · $30.95M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held ALMS?
Deep Track Capital, LP has disclosed ALMS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Deep Track Capital, LP's current position in ALMS?
As of Q3 2026, Deep Track Capital, LP holds 7.47M shares of ALMS (ALUMIS INC), valued at $55.20M, representing 0.92% of its reported portfolio and ranking #34.
Has Deep Track Capital, LP been buying or selling ALMS?
In the latest 13F filing (Q3 2026), Deep Track Capital, LP increased its position in ALMS. The position peaked in Q2 2026 at 6.35M shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include Samsara BioCapital, LLC, Foresite Capital Management V, LLC, venBio Partners LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.